Agilon Health, Inc. $AGL Shares Sold by Wellington Management Group LLP

Key Points

• Wellington Management Group LLP significantly reduced its holdings in Agilon Health by 71.5%, now holding approximately 3.62% of the company post-sale.
• Agilon Health's stock has faced challenges, reporting a negative EPS of ($0.25) and a revenue decline of 5.9% year-over-year, with analysts predicting continued losses for the current year.
• Multiple analysts have lowered their target prices for Agilon Health, with Barclays setting it as low as $1.50 while maintaining a consensus rating of "Hold".

Wellington Management Group LLP lessened its position in Agilon Health, Inc. (NYSE:AGL - Free Report) by 71.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,986,897 shares of the company's stock after selling 37,592,591 shares during the quarter. Wellington Management Group LLP owned about 3.62% of Agilon Health worth $64,893,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in AGL. Wells Fargo & Company MN lifted its position in shares of Agilon Health by 47.5% in the fourth quarter. Wells Fargo & Company MN now owns 144,763 shares of the company's stock valued at $275,000 after acquiring an additional 46,645 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of Agilon Health by 6,931.3% in the fourth quarter. Russell Investments Group Ltd. now owns 36,141 shares of the company's stock valued at $69,000 after acquiring an additional 35,627 shares in the last quarter. Cerity Partners LLC purchased a new position in shares of Agilon Health in the fourth quarter valued at approximately $34,000. Renaissance Technologies LLC lifted its position in Agilon Health by 155.1% during the fourth quarter. Renaissance Technologies LLC now owns 463,300 shares of the company's stock worth $880,000 after buying an additional 281,700 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Agilon Health during the fourth quarter worth approximately $33,000.

Agilon Health Trading Down 2.7%

AGL stock traded down $0.04 during midday trading on Thursday, hitting $1.27. 1,420,173 shares of the company's stock were exchanged, compared to its average volume of 7,190,869. Agilon Health, Inc. has a 1-year low of $0.71 and a 1-year high of $6.08. The business has a 50-day simple moving average of $1.81 and a two-hundred day simple moving average of $2.94. The stock has a market capitalization of $524.24 million, a PE ratio of -1.64 and a beta of 0.14.

Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The firm had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the firm posted ($0.07) earnings per share. The company's quarterly revenue was down 5.9% compared to the same quarter last year. As a group, research analysts expect that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Analyst Ratings Changes

AGL has been the topic of a number of analyst reports. Sanford C. Bernstein reiterated a "market perform" rating and set a $1.40 price objective (down previously from $4.00) on shares of Agilon Health in a research report on Wednesday, August 20th. Robert W. Baird reduced their price objective on Agilon Health from $5.00 to $1.00 and set a "neutral" rating on the stock in a research report on Thursday, August 14th. Benchmark reduced their price objective on Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research report on Wednesday, August 6th. Wells Fargo & Company reduced their price objective on Agilon Health from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 13th. Finally, The Goldman Sachs Group lifted their price objective on Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Four research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $3.07.

Agilon Health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.